Epigenetic Signatures of Salivary Gland Inflammation in Sjögren's Syndrome

Arthritis and Rheumatology

Volumn 68, Issue 12, 2016, Pages 2936-2944

  Cole, Michael B ^a   Quach, Hong ^a   Quach, Diana ^a   Baker, Alice ^a   Taylor, Kimberly E ^b   Barcellos, Lisa F ^a   Criswell, Lindsey A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TRANSCRIPTION FACTOR; UNTRANSLATED RNA; CATHEPSIN X; CTSZ PROTEIN, HUMAN; LMP7 PROTEIN; MEMBRANE PROTEIN; MIRN339 MICRORNA, HUMAN; PROTEASOME; PTPRCAP PROTEIN, HUMAN; SIGNAL PEPTIDE; TAP1 PROTEIN, HUMAN; TNFRSF13B PROTEIN, HUMAN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ANTIGEN PRESENTING CELL; ARTICLE; BIOINFORMATICS; CASE CONTROL STUDY; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC RISK; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PSMB8 GENE; SALIVARY GLAND BIOPSY; SIALOADENITIS; SJOEGREN SYNDROME; TAP1 GENE; ADULT; AGED; GENETIC EPIGENESIS; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; MINOR SALIVA GLAND; PATHOLOGY;

ADULT; AGED; ANTIGEN PEPTIDE TRANSPORTER-1; ANTIGEN-PRESENTING CELLS; CASE-CONTROL STUDIES; CATHEPSIN Z; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; SALIVARY GLANDS, MINOR; SIALADENITIS; SJOGREN'S SYNDROME; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 84997796242     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39792     Document Type: Article

References (48)

1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjögren syndrome. BMJ 2012:344:e3821.
2. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262–9.
3. Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM. Pathogenesis of Sjögren's syndrome: what we know and what we should learn. J Autoimmun 2012;39:4–8.
4. Ice JA, Li H, Adrianto I, Lin PC, Kelly JA, Montgomery CG, et al. Genetics of Sjögren's syndrome in the genome-wide association era. J Autoimmun 2012;39:57–63.
5. Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M, et al. Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 2012;39:272–84.
6. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009;33:3–11.
7. Altorok N, Coit P, Hughes T, Koelsch KA, Stone DU, Rasmussen A, et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheumatol 2014;66:731–9.
8. Thabet Y, le Dantec C, Ghedira I, Devauchelle V, Cornec D, Pers JO, et al. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells. J Autoimmun 2013;41:175–81.
9. Miceli-Richard C, Wang-Renault SF, Boudaoud S, Busato F, Lallemand C, Bethune K, et al. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome. Ann Rheum Dis 2016;75:933–40.
10. Imgenberg-Kreuz J, Sandling JK, Almlöf JC, Nordlund J, Signér L, Norheim KB, et al. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis 2016. E-pub ahead of print.
11. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012;13:86.
12. Shiboski SC, Shiboski CH, Criswell LA, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475–87.
13. Criswell LA. The genetic basis of Sjögren's Syndrome (SS) clinical manifestations from genome-wide association analysis of subphenotype extremes in an international cohort [abstract]. Arthritis Rheumatol 2014;66 Suppl:S228–9.
14. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904–9.
15. Team RDC. R: a language and environment for statistical computing. 2015. URL: http://www.R-project.org.
16. Davis S, Du P, Bilke S, Triche T Jr, Bootwalla M. Methylumi: Handle Illumina methylation data. R package version 2.14.0. 2015. URL: https://www.bioconductor.org/packages/methylumi.
17. Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 2015;12:115–21.
18. Triche TJ Jr, Weisenberger DJ, Van den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res 2013;41:e90.
19. Yousefi P, Huen K, Schall RA, Decker A, Elboudwarej E, Quach H, et al. Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies. Epigenetics 2013;8:1141–52.
20. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013;8:203–9.
21. Rosenbloom KR, Armstrong J, Barber GP, Casper J, Clawson H, Diekhans M, et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res 2015;43:D670–81.
22. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450k DNA methylation data. Bioinformatics 2013;29:189–96.
23. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001;29:1165–88.
24. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841–2.
25. Whitaker JW, Shoemaker R, Boyle DL, Hillman J, Anderson D, Wang W, et al. An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype. Genome Med 2013;5:40.
26. Carlson M. Org.Hs.eg.db: genome wide annotation for human. R package version 3.1.2. URL: http://bioconductor.org/packages/org.Hs.eg.db/.
27. Nakano K, Whitaker JW, Boyle DL, Wang W, Firestein GS. DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 2013;72:110–7.
28. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545–50.
29. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534–44.
30. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 2013;45:1284–92.
31. Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet 2013;45:1361–5.
32. McLeay RC, Bailey TL. Motif enrichment analysis: a unified framework and an evaluation on ChIP data. BMC Bioinformatics 2010;11:165.
33. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res 2014;42:D142–7.
34. Johnsen O, Murphy P, Prydz H, Kolsto AB. Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res 1998;26:512–20.
35. Steffen J, Seeger M, Koch A, Kruger E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell 2010;40:147–58.
36. Hartman SE, Bertone P, Nath AK, Royce TE, Gerstein M, Weissman S, et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 2005;19:2953–68.
37. Portales-Casamar E, Kirov S, Lim J, Lithwick S, Swanson MI, Ticoll A, et al. PAZAR: a framework for collection and dissemination of cis-regulatory sequence annotation. Genome Biol 2007;8:R207.
38. Egerer T, Martinez-Gamboa L, Dankof A, Stuhlmuller B, Dorner T, Krenn V, et al. Tissue-specific up-regulation of the proteasome subunit β5i (LMP7) in Sjögren's syndrome. Arthritis Rheum 2006;54:1501–8.
39. Fox RI, Tornwall J, Michelson P. Current issues in the diagnosis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1999;11:364–71.
40. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010;38:576–89.
41. Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Hara E, Tenen DG, et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene 2006;25:2477–88.
42. Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber ER, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci U S A 2009;106:10746–51.
43. Alevizos I, Alexander S, Turner RJ, Illei GG. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum 2011;63:535–44.
44. Harper KN, Peters BA, Gamble MV. Batch effects and pathway analysis: two potential perils in cancer studies involving DNA methylation array analysis. Cancer Epidemiol Biomarkers Prev 2013;22:1052–60.
45. Barfield RT, Almli LM, Kilaru V, Smith AK, Mercer KB, Duncan R, et al. Accounting for population stratification in DNA methylation studies. Genet Epidemiol 2014;38:231–41.
46. Yousefi P, Huen K, Dave V, Barcellos L, Eskenazi B, Holland N. Sex differences in DNA methylation assessed by 450 K BeadChip in newborns. BMC Genomics 2015;16:911.
47. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999;283:1277–8.
48. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of β-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010;11:587.